Show Notes:
In this episode of Docs Who Lift, the Nadolsky brothers welcome back Dr. Sean Wharton, clinical trialist and one of the leading researchers behind the next generation of oral GLP-1 medications. Together, they break down:
The OASIS-4 trial results on 25mg oral semaglutide and how it stacks up to injectable Wegovy
How orforglipron, Eli Lilly’s new small-molecule GLP-1, differs from peptide-based drugs
Why these new therapies could make weight management more accessible and affordable
The fascinating pharmacology behind “snack molecules” and small-molecule receptor agonists
Common misconceptions about bioavailability, dosing, and side effects
The potential role of oral GLP-1s for patients with mild obesity or cardiometabolic disease
Whether you’re a clinician, researcher, or patient curious about the future of obesity medicine, this conversation offers a clear look at how science is shifting toward needle-free solutions.
Oasis 1 Trial Link
Oasis 4 Trial Link
Attain 1 Trial Link
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Popular Podcasts
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Breakfast Club
The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy, Jess Hilarious, And Charlamagne Tha God!